Health
Remdesivir may only provide modest benefit against ‘moderate’ COVID-19 – Medical Xpress
(HealthDay)—The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
by E.j. Mundell, Healthday Reporter (HealthDay)The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
But a new study finds the drug might not be as effective for ‘moderate’ cases of COVID-19patients hospitalized and perhaps needing oxygen to breathe, but not requiring a ventilator.
The study of nearly 600 such patients found that those who got a five-day course of remdesivir had a “statis…
-
General21 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Business15 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General21 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz